Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: A case report

Cytometry Part B - Clinical Cytometry

Volumn 76, Issue 3, 2009, Pages 218-224

  Naushad, Hina ^a,b   Choi, William W L ^a   Page, Cynthia J ^a   Sanger, Warren G ^c   Weisenburger, Dennis D ^a   Aoun, Patricia ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

CD5+ plasma cells; Flow cytometry; Mantle cell lymphoma; Plasmacytic differentiation

Indexed keywords

CD14 ANTIGEN; CD19 ANTIBODY; CD20 ANTIBODY; CD23 ANTIGEN; CD3 ANTIBODY; CD38 ANTIGEN; CD4 ANTIBODY; CD45 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYCLIN D1; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MONOCLONAL ANTIBODY; PREDNISONE; SYNDECAN 1; VINCRISTINE;

AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW BIOPSY; CANCER CELL; CASE REPORT; CELL CLONE; CELL DIFFERENTIATION; CHROMOSOME 13Q; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERPHASE; LYMPH NODE BIOPSY; MALE; MANTLE CELL LYMPHOMA; PLASMA CELL; PRIORITY JOURNAL;

AGED; CELL DIFFERENTIATION; CLONE CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, MANTLE-CELL; MALE; PLASMA CELLS; SENSITIVITY AND SPECIFICITY;

EID: 66949179609     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20463     Document Type: Article

References (20)

1. Weisenburger DD, Armitage JO. Mantle cell lymphoma - An entity comes of age. Blood 1996;87:4483-4494.
2. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265-276.
3. Weisenburger DD, Vose JM, Greiner TC, Lynch JC, Chan WC, Bierman PJ, Dave BJ, Sanger WG, Armitage JO. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol 2000;64:190-196.
4. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosc F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Fisher RI, Miller TP, LeBlanc M, Ott G, Kvaloy S, Holte H, Delabie J, Staudt LM. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3:185-197.
5. Yatabe Y, Suzuki R, Matsuno Y, Tobinai K, Ichinohazama R, Tamaru J, Mizoguchi Y, Hashimoto Y, Yamaguchi M, Kojima M, Uike N, Okamoto M, Isoda K, Ichimura K, Morishima Y, Seto M, Suchi T, Nakamura S. Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases. Pathol Int 2001;51:747-761.
6. Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Muller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005; 106:4315-4321.
7. Young KH, Chan WC, Fu K, Iqbal J, Sanger WG, Ratashak A, Greiner TC, Weisenburger DD. Mantle cell lymphoma with plasma cell differentiation. Am J Surg Pathol 2006;30:954-961.
8. Seegmiller AC, Xu Y, McKenna RW, Karandikar NJ. Immunophenotypic differentiation between neoplastic plasma cells in mature Bcell lymphoma vs plasma cell myeloma. Am J Clin Pathol 2007;127: 176-181.
9. Weisenburger DD. Mantle-zone lymphoma. An immunohistologic study. Cancer 1984;53:1073-1080.
10. Swerdlow SH, Zukerberg LR, Yang WI, Harris NL, Williams ME. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements. Am J Surg Pathol 1996;20:627-640.
11. Preud'homme JL, Gombert J, Brizard A, Lacotte L, Babin P, Flandrin G. Serum Ig abnormalities in mantle cell lymphoma. Blood 1997; 90:894-896.
12. O'Connor BP, Gleeson MW, Noelle RJ, Erickson LD. The rise and fall of long-lived humoral immunity: Terminal differentiation of plasma cells in health and disease. Immunol Rev 2003;194:61-76.
13. Calame KL, Lin KI, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003;21:205-230.
14. Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 1995;85: 487-494.
15. Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O, Tanaka H, Sakai A, Asaoku H, Kuramoto A. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993;81: 2658-2663.
16. Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, Evans PA, Child JA, Smith GM, Jack AS, Morgan GJ. Circulating plasma cells in multiple myeloma: Characterization and correlation with disease stage. Br J Haematol 1997;97:46-55.
17. Dimopoulos MA, Kiamouris C, Moulopoulos LA. Solitary plasmacytoma of bone and extramedullary plasmacytoma. Hematol Oncol Clin North Am 1999;13:1249-1257.
18. San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sanchez-Guijo F, Sanchez ML, Escribano L, Barez A, Moro MJ, Hernandez J, Aguilera C, Cuello R, Garcia-Frade J, Lopez R, Portero J, Orfao A. Immunophenotypic analysis of Waldenstrom's macroglobulinemia. Semin Oncol 2003;30:187-195.
19. Woehrer S, Streubel B, Chotti A, Hoffmann M, Raderer M. Transformation of MALT lymphoma to pure plasma cell histology after treatment with anti-CD20 rituximab. Leuk Lymphoma 2005;46:1654-1659.
20. Goteri G, Oliveri A, Ranaldi R, Lucesole M, Filosa A, Capretti R, Pieramici T, Leoni P, Rubini C, Fabris G, Lo Muzio L. Bone marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: Comparison with clinical response and patient's outcome. Int J of Immunopathol Pharmacol 2006;19:421-431.